https://www.cnn.com/2023/02/24/health/pfizer-rsv-vaccine-guillain-barre/index.html
CNN
—
Two people who received Pfizer’s respiratory syncytial virus (RSV) vaccine during a clinical trial were later diagnosed with Guillain-Barre syndrome, and the US Food and Drug Administration has asked Pfizer to conduct a safety study if the shot is approved, according to agency documents released Friday.
Become a supporter of this podcast: https://www.spreaker.com/podcast/world-reading-club-w-r-c--5667160/support.